Structured facts
{
"code": "A",
"date": "2026-03-11",
"direction": "A",
"exercise_price": null,
"expiration": null,
"footnotes": {
"F1": "In connection with MMED\u0027s separation from Medtronic plc (\"Medtronic\") effective March 9, 2026 (the \"Separation\"), as further described in MMED\u0027s current report on Form 8-K filed on March 9, 2026, certain restricted stock units and performance share units granted by Medtronic held by the Reporting Person (the \"Medtronic Awards\") were converted into time-vesting restricted stock units denominated in shares of MMED\u0027s common stock (\"MMED RSUs\") pursuant to the terms of the Employee Matters Agreement, dated as of March 1, 2026, by and between Medtronic Group Holding, Inc. and Kangaroo US HoldCo 2, Inc. (the \"EMA\").",
"F2": "Pursuant to the terms of the EMA, the Medtronic Awards were converted into MMED RSUs based, in part, on (i) the average closing trading price of a Medtronic ordinary share for the last three consecutive trading days ending on March 6, 2026 and (ii) the average closing trading price of a share of MMED common stock for three consecutive trading days starting with and including March 9, 2026 (the \"Equity Award Conversion\").",
"F4": "Includes shares to be issued in connection with the vesting of one or more restricted stock units.",
"F5": "Represents the grant of MMED RSUs upon the conversion of certain Medtronic Awards held by the Reporting Person pursuant to the Equity Award Conversion. The MMED RSUs were granted pursuant to the LTIP and vest in three equal installments on July 28, 2026, July 28, 2027 and July 28, 2028."
},
"owners": [
{
"cik": "0002111465",
"name": "Spooner Chad",
"roles": [
"officer"
],
"title": "EVP, Chief Financial Officer"
}
],
"ownership": "D",
"post_shares": "127609",
"price": null,
"row": 2,
"rule_10b5_1": "0",
"security": "Common Stock",
"shares": "127609",
"table": "I",
"underlying_security": null,
"underlying_shares": null
}